Qiang Li

Shenzhen Bay Laboratory (CN)

Research Areas

Discover Papers by Qiang Li

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

3991

Citations

27353

i10-index

508

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
The challenge of mapping the human connectome base...	2017	1426
Guidelines for Diagnosis and Treatment of Primary ...	2018	687
Circular RNA AKT3 upregulates PIK3R1 to enhance ci...	2019	585
Circulating microRNA-1 as a potential novel biomar...	2009	527
Atezolizumab plus bevacizumab versus active survei...	2023	468
Mutant p53 in cancer: from molecular mechanism to ...	2022	440
Selective enhancement filters for nodules, vessels...	2003	347
Caspase-9: structure, mechanisms and clinical appl...	2017	329
Metal-based <i>NanoEnhancers</i> for Future Radiot...	2018	321
Pharmacological effects and pharmacokinetic proper...	2015	284

Publications

1.
The challenge of mapping the human connectome based on diffusion tractography
Year: 2017Citations: 1426DOI: 10.1038/s41467-017-01285-x
2.
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Year: 2018Citations: 687DOI: 10.1159/000488035
3.
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Year: 2019Citations: 585DOI: 10.1186/s12943-019-0969-3
4.
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction
Year: 2009Citations: 527DOI: 10.1016/j.bbrc.2009.11.005
5.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Year: 2023Citations: 468DOI: 10.1016/s0140-6736(23)01796-8
6.
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Year: 2022Citations: 440DOI: 10.1038/s41419-022-05408-1
7.
Selective enhancement filters for nodules, vessels, and airway walls in two‐ and three‐dimensional CT scans
Year: 2003Citations: 347DOI: 10.1118/1.1581411
8.
Caspase-9: structure, mechanisms and clinical application
Year: 2017Citations: 329DOI: 10.18632/oncotarget.15098
9.
Metal-based <i>NanoEnhancers</i> for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells
Year: 2018Citations: 321DOI: 10.7150/thno.22172
10.
Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii
Year: 2015Citations: 284DOI: 10.1016/j.lfs.2015.01.006

About Qiang Li

Qiang Li is a researcher with 3991 publications and 27353 citations. They are affiliated with Shenzhen Bay Laboratory. Their research focuses on . With an h-index of 74, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Qiang Li and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year